News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,675 Results
Type
Article (43495)
Company Profile (293)
Press Release (663887)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (205811)
Career Advice (2026)
Deals (35585)
Drug Delivery (97)
Drug Development (81719)
Employer Resources (173)
FDA (16285)
Job Trends (14974)
News (347806)
Policy (32819)
Tag
Academia (2639)
Accelerated approval (6)
Adcomms (23)
Allergies (86)
Alliances (49984)
ALS (91)
Alzheimer's disease (1386)
Antibody-drug conjugate (ADC) (127)
Approvals (16281)
Artificial intelligence (255)
Autoimmune disease (21)
Automation (16)
Bankruptcy (364)
Best Places to Work (11729)
BIOSECURE Act (20)
Biosimilars (105)
Biotechnology (213)
Bladder cancer (78)
Brain cancer (28)
Breast cancer (280)
Cancer (2270)
Cardiovascular disease (174)
Career advice (1692)
Career pathing (30)
CAR-T (154)
Cell therapy (433)
Cervical cancer (19)
Clinical research (66410)
Collaboration (846)
Compensation (527)
Complete response letters (21)
COVID-19 (2625)
CRISPR (43)
C-suite (246)
Cystic fibrosis (101)
Data (2207)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (270)
Diagnostics (6442)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (123)
Drug pricing (100)
Drug shortages (25)
Duchenne muscular dystrophy (94)
Earnings (86988)
Editorial (36)
Employer branding (21)
Employer resources (147)
Events (113531)
Executive appointments (727)
FDA (17537)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (753)
Gene editing (110)
Generative AI (20)
Gene therapy (318)
GLP-1 (715)
Government (4450)
Grass and pollen (5)
Guidances (59)
Healthcare (18953)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (117)
Indications (29)
Infectious disease (2768)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (317)
IPO (16577)
IRA (40)
Job creations (3670)
Job search strategy (1436)
Kidney cancer (10)
Labor market (38)
Layoffs (477)
Leadership (17)
Legal (7979)
Liver cancer (77)
Lung cancer (324)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (303)
MASH (67)
Medical device (13392)
Medtech (13397)
Mergers & acquisitions (19547)
Metabolic disorders (687)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (90)
Neuropsychiatric disorders (28)
Neuroscience (1925)
NextGen: Class of 2025 (6596)
Non-profit (4561)
Now hiring (39)
Obesity (365)
Opinion (209)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (84)
Parkinson's disease (148)
Partnered (21)
Patents (235)
Patient recruitment (110)
Peanut (46)
People (57815)
Pharmaceutical (66)
Pharmacy benefit managers (18)
Phase I (20751)
Phase II (29228)
Phase III (21772)
Pipeline (1187)
Policy (139)
Postmarket research (2588)
Preclinical (8869)
Press Release (67)
Prostate cancer (106)
Psychedelics (31)
Radiopharmaceuticals (247)
Rare diseases (395)
Real estate (5969)
Recruiting (65)
Regulatory (22472)
Reports (46)
Research institute (2424)
Resumes & cover letters (352)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (132)
Series B (85)
Service/supplier (13)
Sickle cell disease (55)
Special edition (15)
Spinal muscular atrophy (158)
Sponsored (29)
Startups (3645)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (31)
Vaccines (698)
Venture capitalists (41)
Weight loss (236)
Women's health (35)
Worklife (16)
Date
Today (173)
Last 7 days (875)
Last 30 days (2650)
Last 365 days (33091)
2025 (10679)
2024 (35510)
2023 (40357)
2022 (51561)
2021 (56070)
2020 (54431)
2019 (46928)
2018 (35347)
2017 (32490)
2016 (31978)
2015 (37996)
2014 (31700)
2013 (26900)
2012 (29092)
2011 (29755)
2010 (27811)
Location
Africa (745)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38384)
Australia (6311)
California (6141)
Canada (2011)
China (521)
Colorado (265)
Connecticut (278)
Delaware (146)
Europe (82951)
Florida (909)
Georgia (205)
Idaho (58)
Illinois (535)
India (25)
Indiana (307)
Iowa (11)
Japan (161)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (891)
Massachusetts (4598)
Michigan (219)
Minnesota (390)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1724)
New Mexico (28)
New York (1748)
North Carolina (980)
North Dakota (8)
Northern California (2676)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1382)
Puerto Rico (12)
Rhode Island (33)
South America (1120)
South Carolina (22)
South Dakota (1)
Southern California (2300)
Tennessee (101)
Texas (908)
United States (23199)
Utah (180)
Virginia (144)
Washington D.C. (62)
Washington State (588)
West Virginia (3)
Wisconsin (55)
707,675 Results for "seattle genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Gilead and Kite Are Cutting Employees, Closing Seattle, Philadelphia Sites
Gilead’s layoffs include 72 employees at its Seattle location, which will close. Kite will shut down its Philadelphia facility. The layoffs are attributed to aligning resources with long-term strategic goals.
November 15, 2024
·
2 min read
·
Angela Gabriel
Biotech Bay
Avirmax Biopharma Inc. to Present at the 2024 ARVO Annual Meeting in Seattle
Avirmax Biopharma Inc., will make three scientific presentations at the 2024 Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Seattle between May 5th and 9th, 2024.
April 1, 2024
·
2 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Baylor Genetics Joins Child Neurology Society as Official Genetic Testing Partner
April 29, 2025
·
3 min read
Press Releases
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation
March 20, 2025
·
8 min read
Gene therapy
Regeneron’s Gene Therapy Restores Hearing in Patients with Rare Genetic Condition
The treatment, called DB-OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic deafness.
February 24, 2025
·
4 min read
·
Dan Samorodnitsky
Press Releases
Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.
February 7, 2025
·
10 min read
Press Releases
Baylor Genetics to Showcase Genetic Testing Innovations for Rare Disease at ACMG 2025 Annual Clinical Genetics Meeting
March 11, 2025
·
3 min read
Press Releases
Baylor Genetics Presents New Data on Genetic and Functional Testing to Diagnose Mitochondrial Disorders at 2025 ACMG Annual Clinical Genetics Meeting
March 21, 2025
·
3 min read
Genetown
SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that RareCyte Inc., a precision biology company based in Seattle, Washington, is live on SOPHiA GENETICS.
January 18, 2024
·
4 min read
1 of 70,768
Next
